Marvin J. Slepian, MD, JD, a Regents Professor of medicine, radiology and imaging sciences and surgery at the University of Arizona College of Medicine – Tucson and of biomedical engineering at the U of A College of Engineering, received this year’s University Distinguished Innovation and Entrepreneurship Award. Continue reading→

Researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) agent powered by a large language model (LLM) that creates more accurate and informative descriptions of biological processes and their functions in gene set analysis than current systems.Continue reading→

Findings suggest that the patients themselves produce molecules that could reawaken their immune system to battle lung cancerContinue reading→

Suzanne Pfister, an extraordinary leader and public servant whose tenure as Vitalyst Health Foundation’s President and CEO transformed the organization and  inspired paradigm-shifting change across Arizona’s health landscape.
Continue reading→

July 15, 2025 /PRNewswire/ — GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, today announced the company has completed the close of its oversubscribed $53 million Series D equity financing.Continue reading→

• Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters’ proven execution model
• Doubles Waters’ total addressable market to approximately $40 billion, with 5-7% annual growth
• Creates a combined company with pro forma expected 2025 sales of approximately $6.5 billion and adjusted EBITDA of approximately $2.0 billion
• Increases annual recurring revenue to over 70% with over 80% of revenue coming from iconic market-leading brands
• Anticipate approximately $345 million in annualized EBITDA synergies by 2030, including $200 million of cost synergies by year three, and $290 million of revenue synergies by year five
• Delivers an industry-leading financial outlook with mid-to-high single-digit revenue growth, approximately 500 basis points of adjusted operating margin expansion, and mid-teens annualized adjusted EPS growth expected over five years
• Transaction expected to be accretive to adjusted EPS in the first year

Continue reading→

Boston, MA, June 24, 2025 – The Life Sciences Workforce Collaborative (LSWC), formerly the Coalition of State Bioscience Institutes (CSBI), today released its 2025 National Life Sciences Workforce Trends Report, the seventh edition of this landmark study, at the 2025 BIO International Convention in Boston.

Developed in partnership with TEConomy Partners, LLC, with support from InnovATEBIO, the National Biotechnology Education Center, the biennial report captures an evolving talent landscape across the U.S. life sciences sector. Drawing on survey responses from over 500 companies, 200 executive interviews, and 2.9 million job postings, the 2025 edition reflects a more complex, cautious industry posture as companies respond to macroeconomic pressures, talent availability, and rapid digital transformation.¹Continue reading→

A rapid test, developed by an ASU professor working with Mayo Clinic, could be available for use by the end of the year.Continue reading→